Maternal Well-being in the Perinatal Period
Launched by IRCCS SAN RAFFAELE · Jun 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Maternal Well-being in the Perinatal Period," is focused on understanding the mental health of women who are pregnant for the first time. The study looks at important issues such as anxiety, depression, feelings of loneliness, and how mothers cope with these emotions during their pregnancy. Researchers want to learn more about the mental health challenges these women face, particularly in the last few months of pregnancy, and how these feelings may continue to affect them and their relationship with their child for up to 18 months after childbirth.
To participate in this study, women must be at least 18 years old, fluent in Italian, and currently in their first pregnancy, specifically in the last trimester (between 28 and 35 weeks). If they join, participants will share their experiences and feelings over the course of the study, helping researchers gain valuable insights into maternal mental health. This research aims to support better care and resources for expectant mothers, enhancing their overall well-being during and after pregnancy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Adequate understanding of the Italian language
- • Willingness to participate in the study, expressed through the signing of the information sheet, consent declaration, and privacy statement
- • Women experiencing their first pregnancy
- • Women in the last trimester of gestation (28th-35th week of gestation) who will be followed for 18 months after childbirth
- Exclusion Criteria:
- • Age under 18 years old
- • Women who are not able to understand the Italian language
- • Absence of the willingness to participate in the study, expressed through the signing of the information sheet, consent declaration, and privacy statement
- • Women who are not experiencing their first pregnancy
- • Women who are not in the last trimester of gestation (28th-35th week of gestation)
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Trial Officials
Valentina Di Mattei, Professor
Principal Investigator
IRCCS San Raffaele
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported